PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826)

From EU Knowledge Graph
Revision as of 22:31, 21 October 2021 by DG Regio (talk | contribs) (‎Changed an Item: modifying budgets in portugal one item from slovenia)
Jump to navigation Jump to search
Project Q2906826 in Portugal
Language Label Description Also known as
English
PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease.
Project Q2906826 in Portugal

    Statements

    0 references
    204,000.0 Euro
    0 references
    240,000.0 Euro
    0 references
    85.0 percent
    0 references
    26 July 2018
    0 references
    25 July 2022
    0 references
    INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
    0 references
    Q2985732 (Deleted Item)
    0 references

    41°8'58.02"N, 8°36'38.84"W
    0 references
    Porto
    0 references

    Identifiers

    POCI-01-0145-FEDER-031013
    0 references